Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Chinese Traditional and Herbal Drugs ; (24): 5950-5956, 2019.
Article in Chinese | WPRIM | ID: wpr-850623

ABSTRACT

Objective: Screening a plant medicine containing spermidine to promote the fermentation of pingyangmycin (PYM). Methods: Based on the screening method of carbon and nitrogen sources in biological fermentation, the plant medicine with the best promotion effect on PYM was screened out by HPLC method in Lycium ruthenicum, Lycium barbarum, Lycium barbarum bud, Carthamus tinctorius, and Coicis Semen. And the best adding time, amount and frequency were also screened out. Results: The results showed that Lycium barbarum bud had the best effect on PYM fermentation, and the initial adding time was 24 h, the adding interval was 24 h, and the adding frequency was three times. The shaking bottle fermentation level was 21.3 μg/mL when the addition amount was 7 g/L/per batch, and the 25 L tank fermentation level was 37.5 μg/mL when the addition amount was 18 g/L/per batch, which increased by 23.8% and 118.0%, respectively. Compared with the addition of spermidine, the yield was increased by 45.3%. Conclusion: Most plant drugs containing spermidine can promote the fermentation of pingyangmycin, and the selection of Lycium barbarum bud as raw materials for pingyangmycin fermentation meets the production requirements in terms of cost, yield and environmental protection.

2.
Chinese Journal of Medical Aesthetics and Cosmetology ; (6): 370-372, 2010.
Article in Chinese | WPRIM | ID: wpr-382899

ABSTRACT

Objective To evaluate the clinical efficacy of pingyangmycin (PYM) injection on infantile hemangioma located in the parotid gland region. Methods Twelve patients were treated by intralesional injection of PYM. When necessary, the injections were repeated at an interval of one week, but not more than 3-4 sessions within a therapeutic period. Normally, the secondary therapeutic period was performed 1 month later. The general and local adverse responses were recorded and the clinical outcomes were assessed with a follow-up of 1 to 3 years. Results Complete clinical resolutions were achieved in 10 patients. 2 patients received one injection, 3 patients received 2 injections, 3 patients received 3 injections, and 2 patients received 4 injections. The remaining 2 patients with partial resolution received 6 and 7 injections respectively. No clinical recurrence was observed during the follow-up of 1 to 3 years. No ulcerations or postoperative sears in injection regions were presented. The function of facial nerve was remained normality in all patients. The systematic side effects included transient pyrexia and poor appetite appeared in partial patients. No allergy cases were found. Conclusion Treatment of infantile hemangioma located in parotid gland region with PYM injection reveals a high rate of complete clinical resolution, with fair cosmetic results and short treatment time, and it does not damage the facial nerve or form local scar.The treatment time of PYM injection seems to be positively related to size of the lesions.

3.
Chinese Pharmacological Bulletin ; (12)1986.
Article in Chinese | WPRIM | ID: wpr-550300

ABSTRACT

The antineoplastic drugs pingyangmycin ( PYM ) and adriamycin ( ADM ) and biological response modifier thymosin were tested for the effects on concanavalin A ( Con-A ) induced interleukin-2 ( IL-2 ) production by MTT colorimetric assay. When the drug was added to splenocytes of BALB/c mice in the presence of suboptimal dose of Con-A for 24h ,PYM increased IL-2 release over a wide range of doses, and this effect was achieved when using less than 0.01mg/L PYM. However, 10mg/L PYM inhibited IL-2 activity in the supernatant of cultures. ADM was able to enhance the production of IL-2, and thymosin enhance production of IL-2 too.When PYM or ADM applied with thymosin, the additive effects were shown. The activity of IL-2 was increased significantly.

SELECTION OF CITATIONS
SEARCH DETAIL